MedPath

NALMEFENE HYDROCHLORIDE

Nalmefene Hydrochloride Injection

Approved
Approval ID

3abfbffc-9e52-4fc6-ae92-6e0a97f4afe7

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 1, 2023

Manufacturers
FDA

Purdue Pharma L.P.

DUNS: 932323652

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

NALMEFENE HYDROCHLORIDE

PRODUCT DETAILS

NDC Product Code59011-960
Application NumberANDA212955
Marketing CategoryC73584
Route of AdministrationINTRAMUSCULAR, INTRAVENOUS, SUBCUTANEOUS
Effective DateDecember 1, 2023
Generic NameNALMEFENE HYDROCHLORIDE

INGREDIENTS (4)

NALMEFENE HYDROCHLORIDEActive
Quantity: 1 mg in 1 mL
Code: K7K69QC05X
Classification: ACTIB
SODIUM CHLORIDEInactive
Quantity: 9 mg in 1 mL
Code: 451W47IQ8X
Classification: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT
WATERInactive
Code: 059QF0KO0R
Classification: IACT
© Copyright 2025. All Rights Reserved by MedPath
NALMEFENE HYDROCHLORIDE - FDA Approval | MedPath